Frontiers in Oncology,
Journal Year:
2022,
Volume and Issue:
12
Published: March 10, 2022
Background
Lymph
node
metastasis
(LNM)
commonly
occurs
in
gastric
cancer
(GC)
and
is
tightly
associated
with
poor
prognosis.
Exosome-mediated
lymphangiogenesis
has
been
considered
an
important
driver
of
LNM.
Whether
exosomes
directly
transmit
the
LNM
phenotype
between
GC
cells
its
mechanisms
remain
elusive.
Methods
A
highly
lymphatic
metastatic
cell
line
(HGC-27-L)
was
established
by
serial
passage
parental
HGC-27
BALB/c
nude
mice.
The
capacities
migration,
invasion
LNM;
fatty
acid
oxidation
(FAO)
levels;
role
exosome-transferred
were
compared
among
HGC-27-L,
primary
AGS.
Exosomes
derived
from
sera
separately
isolated
using
ultracentrifugation
ExoQuick
exosome
precipitation
solution,
characterized
transmission
electron
microscopy,
Nanosight
western
blotting.
Transwell
assay
models
conducted
to
evaluate
vitro
vivo
.
β-oxidation
rate
CPT1
activity
measured
assess
FAO.
CPT1A
inhibitor
etomoxir
used
determine
Label-free
LC-MS/MS
proteome
analysis
screened
differential
protein
profiling
HGC-27-exosomes
AGS-exosomes.
Small
interference
RNAs
YAP
verteporfin
elucidate
mechanism
exosomal
CD44.
TCGA
data
analysis,
immunochemistry
staining
ELISA
performed
analyze
expression
correlation
clinical
significance
CD44/YAP/CPT1A.
Results
FAO
increased
indispensable
for
sustaining
capacity.
Lymphatic
cell-exosomes
conferred
capacity
on
FAO-dependent
way.
Mechanistically,
CD44
identified
be
enriched
a
critical
cargo
regulating
exosome-mediated
transmission,
possibly
modulating
RhoA/YAP/Prox1/CPT1A
signaling
axis.
Abnormal
CD44/YAP/CPT1A
tissues
correlated
each
other
status,
stages,
survival.
Serum
concentration
positively
tumor
burden
lymph
nodes.
Conclusions
We
uncovered
novel
mechanism:
transmits
via
YAP-CPT1A-mediated
reprogramming
perspective
exosomes-transferred
phenotype.
This
provides
potential
therapeutic
targets
non-invasive
biomarker
patients
Signal Transduction and Targeted Therapy,
Journal Year:
2020,
Volume and Issue:
5(1)
Published: Oct. 19, 2020
Abstract
Metabolic
reprogramming
is
reported
to
be
one
of
the
hallmarks
cancer,
which
an
adaptive
mechanism
by
fast-growing
cancer
cells
adapt
their
increasing
energy
demands.
Recently,
extracellular
vesicles
(EVs)
known
as
exosomes
have
been
recognized
crucial
signaling
mediators
in
regulating
tumor
microenvironment
(TME).
Meanwhile,
TME
a
highly
heterogeneous
ecosystem
incorporating
cells,
fibroblasts,
adipocytes,
endothelial
mesenchymal
stem
and
matrix.
Accumulated
evidence
indicates
that
may
transfer
biologically
functional
molecules
recipient
facilitate
progression,
angiogenesis,
metastasis,
drug
resistance,
immunosuppression
metabolism
surrounding
stromal
cells.
In
this
review,
we
present
role
underlying
how
exacerbate
development
through
metabolic
reprogramming.
addition,
will
also
discuss
potential
targeting
process
biomarkers
for
diagnosis
prognosis,
exosomes-mediated
targets
therapy.
Furthermore,
better
understanding
link
between
reprogramming,
impact
on
would
provide
novel
insights
prevention
treatment
future.
Molecular Cancer,
Journal Year:
2019,
Volume and Issue:
18(1)
Published: Aug. 13, 2019
Ovarian
cancer
is
one
of
the
most
common
gynecological
malignancies.
Upon
initial
diagnosis,
majority
patients
present
with
widespread
metastatic
growth
within
peritoneal
cavity.
This
occurs
in
stages,
formation
a
pre-metastatic
niche
occurring
prior
to
macroscopic
tumor
cell
invasion.
Exosomes
released
by
primary
ovarian
are
small
extracellular
vesicles
which
prepare
distant
microenvironment
for
accelerated
They
regulate
intercellular
communication
between
cells
and
normal
stroma,
cancer-associated
fibroblasts,
local
immune
microenvironment.
In
this
review,
we
highlight
emerging
roles
exosomes
as
coordinators
formation,
biomarkers
amenable
liquid
biopsy,
targets
chemotherapy.
Frontiers in Immunology,
Journal Year:
2019,
Volume and Issue:
10
Published: Feb. 6, 2019
The
emergence
of
disseminated
metastases
remains
the
primary
cause
mortality
in
cancer
patients.
Formation
pre-metastatic
niche
(PMN),
which
precedes
establishment
tumor
lesions,
is
critical
for
metastases.
Bone
marrow-derived
myeloid
cells
(BMDCs)
are
indispensable
PMN
formation.
Myeloid-derived
suppressor
(MDSCs)
a
population
immature
that
accumulate
patients
with
and
appear
early
PMN.
mechanisms
by
MDSCs
establish
microenvironment
distant
organs
largely
unknown,
although
play
an
essential
role
metastasis.
Here,
we
summarize
key
factors
associated
recruitment
activation
review
regulate
formation
evolution.
Finally,
predict
potential
value
detection
therapy.
ACS Nano,
Journal Year:
2020,
Volume and Issue:
14(9), P. 12133 - 12147
Published: Aug. 11, 2020
Extracellular
vesicles
(EVs)
derived
from
mesenchymal
stem
cells
(MSC-EVs)
have
been
recognized
as
a
promising
cell-free
therapy
for
acute
kidney
injury
(AKI),
which
avoids
safety
concerns
associated
with
direct
cell
engraftment.
However,
low
stability
and
retention
of
MSC-EVs
limited
their
therapeutic
efficacy.
RGD
(Arg-Gly-Asp)
peptide
binds
strongly
to
integrins,
identified
on
the
surface
MSC-EV
membranes;
yet
has
not
applied
EV
scaffolds
enhance
prolong
bioavailability.
Here,
we
developed
hydrogels,
hypothesized
could
augment
efficacy
in
treatment
AKI
models.
In
vivo
tracking
labeled
EVs
revealed
that
hydrogels
increased
EVs.
Integrin
gene
knockdown
experiments
confirmed
EV–hydrogel
interaction
was
mediated
by
RGD–integrin
binding.
Upon
intrarenal
injection
into
mouse
models,
EV-RGD
provided
superior
rescuing
effects
renal
function,
attenuated
histopathological
damage,
decreased
tubular
injury,
promoted
proliferation
early
phases
AKI.
also
augmented
antifibrotic
chronic
stages.
Further
analysis
presence
microRNA
let-7a-5p
served
mechanism
contributing
reduced
apoptosis
elevated
autophagy
conclusion,
facilitated
MSC-derived
let-7a-5p-containing
EVs,
improving
reparative
potential
against
This
study
an
scaffold
increase
integrin-mediated
loading
turn
improved
repair;
therefore
this
strategy
shed
light
application
potentiated
efficiency.
Cell Death and Disease,
Journal Year:
2020,
Volume and Issue:
11(7)
Published: July 27, 2020
Abstract
Extracellular
vesicles
(EVs)
and
particles
(EPs)
have
recently
emerged
as
active
carriers
of
molecular
biomarkers
mediators
intercellular
communication.
While
most
investigations
focused
exclusively
on
the
protein,
lipid
RNA
constituents
these
extracellular
entities,
EV/EP
DNA
remains
poorly
understood,
despite
being
found
in
association
with
virtually
all
populations.
The
functional
potential
has
been
proposed
a
number
pathological
states,
including
malignancies
autoimmune
diseases.
Moreover,
effectiveness
cell-free
biomarker
choice
emerging
liquid
biopsy
applications
highlights
role
that
may
play
novel
disease
biomarker.
In
this
review,
we
provide
comprehensive
overview
studies
conducted
to
date,
particular
focus
roles
mediator
various
pathologic
states.
We
also
review
what
is
currently
known
about
origins,
structure,
localisation
distribution
DNA,
highlighting
current
controversies
well
opportunities
for
future
investigation.
Journal of Experimental & Clinical Cancer Research,
Journal Year:
2020,
Volume and Issue:
39(1)
Published: April 16, 2020
Tumor
microenvironment
(TME)
is
the
internal
environment
in
which
tumor
cells
survive,
consisting
of
cells,
fibroblasts,
endothelial
and
immune
as
well
non-cellular
components,
such
exosomes
cytokines.
Exosomes
are
tiny
extracellular
vesicles
(40-160nm)
containing
active
substances,
proteins,
lipids
nucleic
acids.
carry
biologically
miRNAs
to
shuttle
between
TME,
thereby
affecting
development.
Tumor-derived
exosomal
induce
matrix
reprogramming
creating
a
that
conducive
growth,
metastasis,
escape
chemotherapy
resistance.
In
this
review,
we
updated
role
process
TME
reshaping.
Frontiers in Immunology,
Journal Year:
2021,
Volume and Issue:
12
Published: July 14, 2021
Extracellular
vesicles
(EVs)
are
released
by
most
cell
types
as
part
of
an
intracellular
communication
system
in
crucial
processes
such
inflammation,
proliferation,
and
immune
response.
However,
EVs
have
also
been
implicated
the
pathogenesis
several
diseases,
cancer
numerous
infectious
diseases.
An
important
feature
is
their
ability
to
deliver
a
wide
range
molecules
nearby
targets
or
over
long
distances,
which
allows
mediation
different
biological
functions.
This
delivery
mechanism
can
be
utilized
for
development
therapeutic
strategies,
vaccination.
Here,
we
highlighted
studies
from
historical
perspective,
with
respect
current
investigations
on
EV-based
vaccines.
For
example,
vaccines
based
exosomes
derived
dendritic
cells
proved
simpler
terms
management
cost-effectiveness
than
Recent
evidence
suggests
that
leveraged
therapeutics
induce
strong
anti-tumor
responses.
Moreover,
shown
exciting
promising
results
against
We
summarized
obtained
completed
clinical
trials
conducted
usage
exosome-based
treatment
cancer,
more
recently,
coronavirus
disease.
Molecular Cancer,
Journal Year:
2024,
Volume and Issue:
23(1)
Published: Jan. 19, 2024
Abstract
The
production
and
release
of
tumor-derived
small
extracellular
vesicles
(TDSEVs)
from
cancerous
cells
play
a
pivotal
role
in
the
propagation
cancer,
through
genetic
biological
communication
with
healthy
cells.
TDSEVs
are
known
to
orchestrate
invasion-metastasis
cascade
via
diverse
pathways.
Regulation
early
metastasis
processes,
pre-metastatic
niche
formation,
immune
system
regulation,
angiogenesis
initiation,
matrix
(ECM)
remodeling,
modulation,
epithelial-mesenchymal
transition
(EMT)
among
pathways
regulated
by
TDSEVs.
MicroRNAs
(miRs)
carried
within
as
double-edged
sword
can
either
promote
or
inhibit
cancer
progression.
serve
excellent
markers
for
detection
tumors,
tumor
metastases.
From
therapeutic
point
view,
risk
may
be
reduced
limiting
On
other
hand,
represent
promising
approach
vivo
delivery
cargo
present
review
article
discusses
recent
developments
current
views
field
research
clinical
applications.
World Journal of Clinical Cases,
Journal Year:
2019,
Volume and Issue:
7(2), P. 171 - 190
Published: Jan. 26, 2019
Exosomes
are
microvesicles,
measuring
30-100
nm
in
diameter.
They
widely
distributed
body
fluids,
including
blood,
bile,
urine
and
saliva.
Cancer-derived
exosomes
carry
a
wide
variety
of
DNA,
RNA,
proteins
lipids,
may
serve
as
novel
biomarkers
cancer.To
summarize
the
performance
exosomal
cancer
diagnosis
prognosis.Relevant
publications
literature
were
identified
by
search
"PubMed"
database
up
to
September
11,
2018.
The
quality
included
studies
was
assessed
QUADAS-2
REMARK.
For
assessment
diagnostic
biomarkers,
47
2240
patients
from
30
included.Our
results
suggested
that
these
had
excellent
ability
various
types
cancer,
with
good
sensitivity
specificity.
prognostic
markers,
50
4797
42
included.
We
observed
values
overall
survival,
disease-free
survival
recurrence-free
survival.Exosomes
can
function
potential
prognosis.
Cell Death and Disease,
Journal Year:
2021,
Volume and Issue:
12(9)
Published: Sept. 8, 2021
Metastasis
is
the
main
cause
of
death
in
patients
with
advanced
lung
cancer.
The
exosomes
released
by
cancer
cells
create
tumor
microenvironment,
and
then
accelerate
metastasis.
Cancer-derived
are
considered
to
be
driving
force
for
metastasis
niche
formation
at
foreign
sites,
but
mechanism
Non-small
cell
carcinoma
(NSCLC)
unclear.
In
metastatic
NSCLC
patients,
expression
level
miR-3157-3p
circulating
was
significantly
higher
than
that
non-metastatic
patients.
Here,
we
found
can
transferred
from
vascular
endothelial
through
exosomes.
Our
work
indicates
exosome
involved
pre-metastatic
before
may
used
as
a
blood-based
biomarker
Exosome
has
regulated
VEGF/MMP2/MMP9
occludin
targeting
TIMP/KLF2,
thereby
promoted
angiogenesis
increased
permeability.
addition,
vivo.